ESR and fibrinogen: an old inflammation test and the protein behind it

The erythrocyte sedimentation rate (ESR) is the distance red blood cells fall in a vertical tube of blood in one hour, reported in millimetres per hour (mm/hr). In inflammation, proteins such as fibrinogen and immunoglobulins make red cells stack together and fall faster. Fibrinogen itself is a clotting protein made by the liver; it is turned into fibrin when blood clots, and it rises as part of the acute-phase response. It is reported in mg/dL or g/L (100 mg/dL is 1 g/L).

The ranges

ESR rises with age even in healthy people, which is why the simple age rule exists: a 70-year-old woman's upper limit by that rule is 40 mm/hr. Neither test has a guideline-defined "optimal" level for general health. Fibrinogen ranges vary by method, and some labs report different intervals.

What raises and lowers them

• ESR up: infection, autoimmune and inflammatory disease, anaemia, kidney disease, pregnancy, older age, some cancers such as myeloma and lymphoma, and anything that raises fibrinogen or antibodies.
• ESR down: a high red cell count (polycythaemia), abnormally shaped red cells, very high white counts, and delays in processing the sample.
• Fibrinogen up: inflammation and infection, smoking, older age, excess weight, pregnancy.
• Fibrinogen down: severe liver disease, disseminated intravascular coagulation, and some inherited conditions. Low fibrinogen raises bleeding risk.

What they are used for, and what they predict

ESR is used mostly to support or monitor specific diagnoses, such as giant cell arteritis, polymyalgia rheumatica and rheumatoid arthritis. MedlinePlus is clear that an abnormal ESR does not prove any particular condition. It changes more slowly than CRP, rising over days and taking weeks to fall, so the two often disagree after an illness.

Fibrinogen has strong cohort data. The Fibrinogen Studies Collaboration (JAMA, 2005) pooled 154,211 participants from 31 prospective studies without known heart disease or stroke. Adjusted only for age and sex, each 1 g/L higher usual fibrinogen came with a hazard ratio of 2.42 for coronary heart disease. After adjusting for established risk factors, the hazard ratios for heart disease and stroke fell to about 1.8. There was no threshold within the usual range, and the authors said whether fibrinogen causes disease needed more research. Fibrinogen is not used in guideline risk scores.

On GLP-1 drugs and weight loss

The pivotal semaglutide and tirzepatide trials do not report ESR or fibrinogen. Since weight loss lowers CRP and since fibrinogen is part of the same acute-phase response driven by IL-6, a modest fall is plausible, but there is no trial number to cite. Anaemia from low iron intake would push ESR up, which is one more reason to read it with a blood count and ferritin.

How to test

• ESR needs a fresh sample. It should be run promptly, or stored as the lab directs; delays change the result.
• Fibrinogen is drawn into a citrate (light blue) tube and is sensitive to a difficult draw or a short-filled tube.
• Be well. Both rise after infection and injury, and ESR can stay up for weeks.
• Pair them with hs-CRP and a full blood count to make sense of a result.

Tracking it in Peptide AI

In Peptide AI, ESR and fibrinogen sits in the inflammatory panel. The app reads it from a lab PDF or manual entry, scores the panel from 0 to 100 alongside an overall grade, flags values that warrant prompt physician consultation, and plots each result against your dose timeline. Log the draw date, whether you fasted, and anything unusual in the days before, such as illness, a hard session or a dose step, so the next result is compared like with like. Bloodwork tracking shows the series next to the dose log, weight and side effects, and the panels page lists every marker the app groups. More markers are in the bloodwork guides.